Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;75(12):1779–1781. doi: 10.1038/bjc.1997.303

Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma.

J Gilbert 1, M D Norris 1, G M Marshall 1, M Haber 1
PMCID: PMC2223599  PMID: 9192981

Abstract

To determine the specificity of neuroendocrine protein gene product (PGP9.5) gene transcripts for detecting micrometastatic neuroblastoma, we have used a highly sensitive polymerase chain reaction (PCR) technique to evaluate expression of this gene in normal blood and bone marrow. While expression of the tyrosine hydroxylase gene was not detected in any normal sample, low-level PGP9.5 expression was detected in eight out of ten blood and seven of 12 marrow samples. PGP9.5 gene transcripts in normal tissues have the potential to interfere with the detection of micrometastatic neuroblastoma.

Full text

PDF
1779

Images in this article

1780Figure 1
on p.1780

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betz C., Papadopoulos T., Buchwald J., Dämmrich J., Müller-Hermelink H. K. Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lung carcinomas: detection by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995 Oct 1;55(19):4283–4286. [PubMed] [Google Scholar]
  2. Burchill S. A., Bradbury F. M., Selby P., Lewis I. J. Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Eur J Cancer. 1995;31A(4):553–556. doi: 10.1016/0959-8049(95)00053-l. [DOI] [PubMed] [Google Scholar]
  3. Burchill S. A., Bradbury F. M., Smith B., Lewis I. J., Selby P. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA. Int J Cancer. 1994 Jun 1;57(5):671–675. doi: 10.1002/ijc.2910570510. [DOI] [PubMed] [Google Scholar]
  4. Chelly J., Concordet J. P., Kaplan J. C., Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2617–2621. doi: 10.1073/pnas.86.8.2617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  6. Datta Y. H., Adams P. T., Drobyski W. R., Ethier S. P., Terry V. H., Roth M. S. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol. 1994 Mar;12(3):475–482. doi: 10.1200/JCO.1994.12.3.475. [DOI] [PubMed] [Google Scholar]
  7. Foss A. J., Guille M. J., Occleston N. L., Hykin P. G., Hungerford J. L., Lightman S. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer. 1995 Jul;72(1):155–159. doi: 10.1038/bjc.1995.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ghossein R. A., Scher H. I., Gerald W. L., Kelly W. K., Curley T., Amsterdam A., Zhang Z. F., Rosai J. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol. 1995 May;13(5):1195–1200. doi: 10.1200/JCO.1995.13.5.1195. [DOI] [PubMed] [Google Scholar]
  9. Hoon D. S., Doi F., Giuliano A. E., Schmid P., Conrad A. J. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer. 1995 Aug 1;76(3):533–535. doi: 10.1002/1097-0142(19950801)76:3<533::aid-cncr2820760330>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  10. Krismann M., Todt B., Schröder J., Gareis D., Müller K. M., Seeber S., Schütte J. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol. 1995 Nov;13(11):2769–2775. doi: 10.1200/JCO.1995.13.11.2769. [DOI] [PubMed] [Google Scholar]
  11. Mattano L. A., Jr, Moss T. J., Emerson S. G. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res. 1992 Sep 1;52(17):4701–4705. [PubMed] [Google Scholar]
  12. Miyajima Y., Kato K., Numata S., Kudo K., Horibe K. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer. 1995 Jun 1;75(11):2757–2761. doi: 10.1002/1097-0142(19950601)75:11<2757::aid-cncr2820751120>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  13. Mori M., Mimori K., Inoue H., Barnard G. F., Tsuji K., Nanbara S., Ueo H., Akiyoshi T. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995 Aug 1;55(15):3417–3420. [PubMed] [Google Scholar]
  14. Moss T. J., Sanders D. G. Detection of neuroblastoma cells in blood. J Clin Oncol. 1990 Apr;8(4):736–740. doi: 10.1200/JCO.1990.8.4.736. [DOI] [PubMed] [Google Scholar]
  15. Naito H., Kuzumaki N., Uchino J., Kobayashi R., Shikano T., Ishikawa Y., Matsumoto S. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer. 1991;27(6):762–765. doi: 10.1016/0277-5379(91)90184-f. [DOI] [PubMed] [Google Scholar]
  16. Noguchi S., Aihara T., Nakamori S., Motomura K., Inaji H., Imaoka S., Koyama H. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer. 1994 Sep 1;74(5):1595–1600. doi: 10.1002/1097-0142(19940901)74:5<1595::aid-cncr2820740516>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  17. Noonan K. E., Beck C., Holzmayer T. A., Chin J. E., Wunder J. S., Andrulis I. L., Gazdar A. F., Willman C. L., Griffith B., Von Hoff D. D. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7160–7164. doi: 10.1073/pnas.87.18.7160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sarkar G., Sommer S. S. Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science. 1989 Apr 21;244(4902):331–334. doi: 10.1126/science.2565599. [DOI] [PubMed] [Google Scholar]
  19. Smith M. R., Biggar S., Hussain M. Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res. 1995 Jun 15;55(12):2640–2644. [PubMed] [Google Scholar]
  20. Thompson R. J., Doran J. F., Jackson P., Dhillon A. P., Rode J. PGP 9.5--a new marker for vertebrate neurons and neuroendocrine cells. Brain Res. 1983 Nov 14;278(1-2):224–228. doi: 10.1016/0006-8993(83)90241-x. [DOI] [PubMed] [Google Scholar]
  21. Wilson P. O., Barber P. C., Hamid Q. A., Power B. F., Dhillon A. P., Rode J., Day I. N., Thompson R. J., Polak J. M. The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol. 1988 Feb;69(1):91–104. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES